Caplacizumab as frontline therapy in addition to standard treatment in iTTP

Detalles Bibliográficos
Autores principales: Cid, Joan, Lozano, Miquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196776/
https://www.ncbi.nlm.nih.gov/pubmed/36469553
http://dx.doi.org/10.1182/bloodadvances.2022009448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196776/
https://www.ncbi.nlm.nih.gov/pubmed/36469553
http://dx.doi.org/10.1182/bloodadvances.2022009448

Ejemplares similares